Related Experiment Video
Updated: Feb 17, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
Stakeholders' perceptions on competency and assessment program of entry-level pharmacists in developing countries
Isaac Asante1, Irene Andoh2, Arno M M Muijtjens3
1Kintampo Health Research Centre Kintampo, Ghana.
Objectives:
To assess the stakeholders' perceptions on the competency of entry-level pharmacists and the use of written licensure examination as the primary assessment for licensure decisions on entry-level pharmacists who have completed the Pharmacy Internship Program1 (PIP) in developing countries.
Method:
A cross-sectional survey was conducted among stakeholders in which they completed a web-based 21-item pre-tested questionnaire to determine their views regarding the competency outcomes and assessment program for entry-level pharmacist.
Results:
The stakeholders rated the entry-level pharmacists to possess all competencies except research skills. Stakeholders suggested improvement of the program by defining the competency framework and training preceptors. However, stakeholders disagree on using written examination as the primary assessment for licensure decision and suggested the incorporation of other performance-based assessments like preceptor's assessment reports.
Conclusion:
Stakeholders are uncertain on entry-level pharmacists in developing countries possessing adequate research competencies and think their assessment program for licensure need more than written examination to assess all required competencies.
More Related Videos
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Analysis of Population Pharmacokinetic Data
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Dosage Regimens: Partial Pharmacokinetic Parameters
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

